Please assess the completion status of the following clinical trial:

Trial Title: Proton Beam Radiation Therapy for Intraocular and Periocular Retinoblastoma

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~1. Active or recurrent retinoblastoma patient eligible for treatment of external beam radiation therapy.~2. A parent or guardian who can provide informed consent to a minor or child participant.~3. No concurrent infection.~4. No contraindication for repeated general anesthesia/sedation.~Exclusion Criteria:~1. Inability to return for multiple examinations under anesthesia.~2. Medical contraindication for exams under anesthesia/sedation.~3. Unreliable follow-up.

- Gender: ALL
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Proton Beam Radiation Therapy (Type: EXPERIMENTAL): Radiation given daily for 5 days in a row each week (except for Saturdays, Sundays, and holidays). The whole treatment will take about 4-6 weeks. Ophthalmic examination under anesthesia including dilated eye exam, ocular fundus photography (Ret-Cam), ocular echography and neuro-radiologic assessment (as deemed necessary)

Based on this trial design, predict the completion outcome and termination type (if applicable).